QSAR and docking based lead optimization of nitrogen heterocycles for enhanced prostaglandin EP2 receptor agonistic potency

D Jawarkar, Rahul and E.A. Zaki, Magdi and A. Al-Hussain, Sami and Samad, Abdul and Chiau Ming, Long and Rashid, Summya and M. Elossaily, Gehan and Yadav, Susmita and Mali, Suraj (2024) QSAR and docking based lead optimization of nitrogen heterocycles for enhanced prostaglandin EP2 receptor agonistic potency. Chemical Physics Impact, 8. ISSN 2667-0224

[img] Text (Research Article)
1-s2.0-S2667022424000288-main.pdf - Published Version

Download (9MB)
Official URL: https://www.sciencedirect.com/science/article/pii/...

Abstract

In the existing effort, a dataset of 309 experimentally screened molecules for in vitro (Ki) agonist potential for Prostaglandin E2 (PGE2) receptor 2 subtype (EP2), which is a metabolite of arachidonic acid that binds with and regulates cellular responses to PGE2, was investigated in the QSAR (Quantitative structure–activity relationship) study. A six-parameter QSAR model was developed that meets the specified values ​​for internal and external validation as well as random parameters such as R2tr = 0.808, Q2LMO = 0.794, R2ex = 0.781. Insightful and quantitative opinion reveals several underappreciated and distinct structural features that are responsible for the agonist potency of these molecules on Prostaglandin EP2 receptor such as; the hydrogen atom is correct 2 bonds from the donor atom, the sp2 hybridized carbon atom is correct 2 bonds from the cyclic nitrogen atom, and so on. The developed QSAR model captures the narrative as well as the novel pharmacophoric features. The QSAR effect was further demonstrated using the reported crystalline buildings of CP533536 with the Prostaglandin EP2 receptor activity. The evaluation led to the identification of valuable new pharmacophoric properties that will be used to optimize lead compounds in the future.

Item Type: Article
Uncontrolled Keywords: Prostaglandin EP2 Receptor QSAR Pharmacophoric features Crystal structures Lead compounds
Subjects: Q Science > Q Science (General)
Q Science > QD Chemistry
R Medicine > RM Therapeutics. Pharmacology
R Medicine > RS Pharmacy and materia medica
Depositing User: ePrints deposit
Date Deposited: 29 Aug 2024 13:39
Last Modified: 29 Aug 2024 13:39
URI: http://eprints.tiu.edu.iq/id/eprint/1551

Actions (login required)

View Item View Item